CMO Chart Subscribe

Adam Lenkowsky

Executive Vice President, Chief Commercial Officer, Bristol Myers Squibb

Healthcare & Pharma · B2B · Enterprise

Named in: S&P 500 company

234
outside the Top 100 Preliminary — November 2026 score 40.9

109 in Enterprise · 122 in B2B · 6 of 43 in Healthcare & Pharma

450 400 350 300 250 200 150
90% range of the rank: the data cannot tell these places apart Nov range 167 to 446

Top signals: Quoted in finance.biggo.com (Oct 29); Quoted in Yahoo Finance (Oct 29); 3 LinkedIn posts in 90 days, median engagement 204

Score breakdown

Measures on a 0 to 100 scale against this month's base of 2,056 CMOs.

40.9 out of 100: the weighted sum of the measures below.

  1. Visibility 30% of this score · last 90 days 24.5

    How much the press wrote about them. An interview or a column counts in full, a quote in a story about the company counts a little, a passing mention or a press release counts zero. Big-company coverage is scaled down so the employer's brand does not carry the person.

  2. Engagement 20% of this score · last 90 days 75.9

    How people respond to their LinkedIn posts: the median post, both in absolute terms and per 1,000 followers, so a huge account does not win by size alone.

  3. Authority 20% of this score · last 12 months, fading 21.7

    The longer track record: press over the past year with older pieces fading, plus awards and major lists.

  4. AI recall 15% of this score · quarterly 54.3

    Whether AI assistants know who they are without searching the web, asked several times per model and graded by a separate check. Wrong answers do not count.

  5. Consistency 15% of this score · last 90 days 39.1

    Showing up steadily: active weeks on LinkedIn and months with press, on a square-root curve, so posting three times a day does not help.

LinkedIn, last 90 days

Followers
21,146
Own posts
3
Active weeks of 13
3
Median engagement per post
204

Engagement is reactions + 2 × comments + 3 × reposts on the person's own posts; reposts of company content are not counted. LinkedIn profile.

Press, awards and talks

Earned coverage from the last 12 months that we confirmed is about Adam Lenkowsky, not a namesake. Each item links to the source. Press releases and company newsrooms are not counted.

  1. QuotedT3 [Bristol-Myers Squibb Q3 2026 Earnings Call] BMS Raises Full-Year Guidance for Third Time as Revenue Climbs 7% to $13.1B; Eliquis Surges 26% Ahead of European Patent Cliff (opens in a new tab) · finance.biggo.com
  2. QuotedT3 Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge (opens in a new tab) · Yahoo Finance
  3. QuotedT3 Bristol Myers Declines on Expansion (opens in a new tab) · TradingView

Rank history starts with this chart. From the next chart on, this page shows each month's rank and range.